The clue for the 5th patient in the USA is that Lanza stated that the patient was treated a few weeks following the Lancet publication. Lancet was published on Jan 23 so that the latest patient to be treated would be early to mid Feb. It could only be the 2nd AMD in the first Cohort. The Europe patient was treated in Jan.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.